Biomarkers, CDx & Precision Medicine US

Biomarkers, CDx & Precision Medicine US has spent a decade convening the people defining the field. The 2026 edition is the largest yet. Three co-located programmes, six tracks per day, a regulatory line-up that includes two reserved FDA seats alongside Merck and AstraZeneca's senior regulatory voices, and a 40,000-strong global community feeding into it. 

Barco´s offer includes an ultra-high definition medical grade display designed exclusively for Digital Pathology. With regulatory clearances for use including primary diagnosis, it’s the first display that you can confidently integrate into your workflow with multiple whole slide imaging systems. You will be able to work with superior imaging technology and analyze your histological samples confidently, with unprecedented visual richness. Additionally Barco offers an AI-powered software “SlideRightQA” to boost lab´s quality assurance process

Barco is a global technology leader that develops networked  solutions for the entertainment, enterprise and healthcare markets. Our solutions make a visible impact in diverse markets.